Article info
Reviews
Are we there yet? Bevacizumab therapy for retinopathy of prematurity
- Correspondence to Professor Brian A Darlow, Department of Paediatrics, Christchurch School of Medicine and Health Sciences, University of Otago Christchurch, PO Box 4345, Christchurch 8140, New Zealand; brian.darlow{at}otago.ac.nz
Citation
Are we there yet? Bevacizumab therapy for retinopathy of prematurity
Publication history
- Received October 6, 2011
- Accepted November 23, 2011
- First published December 30, 2011.
Online issue publication
February 15, 2013
Article Versions
- Previous version (30 December 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions